Royalty Pharma
RPRX
#1045
Rank
S$24.62 B
Marketcap
$41.79
Share price
-0.65%
Change (1 day)
6.60%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2024 (TTM): S$2.51 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are S$2.26 Billion. In 2023 the company made an earning of S$2.56 Billion, an increase over its 2022 earnings that were of S$0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$2.51 B-2.06%
2023 S$2.56 B351.47%
2022 S$0.56 B-70.3%
2021 S$1.91 B-24.3%
2020 S$2.52 B-31.9%
2019 S$3.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$10.2 Million-100.39%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.21 B 252.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.79 B 428.38%๐Ÿ‡บ๐Ÿ‡ธ USA